Literature DB >> 10619382

Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus nutans.

C Yoosook1, Y Panpisutchai, S Chaichana, T Santisuk, V Reutrakul.   

Abstract

Barleria lupulina Lindl. and Clinacanthus nutans (Burm. f.) Lindau, both belonging to the family Acantaceae, are well-known medicinal plants used in Thai folklore medicine. Virucidal effects of organic extracts of these two plants against herpes simplex virus type 2 strain G, HSV-2 (G), the standard HSV-2 strain were noted. The extracts were assessed for intracellular activities against HSV-2 (G) and five clinical HSV-2 isolates. B. lupulina extract exhibited activity against all five isolates but not the standard strain while that of C. nutans did not show any activity against these viruses as determined by plaque inhibition assay. When the activities were verified by yield reduction assay, anti-HSV-2 activities of B. lupulina extract were observed against HSV-2 (G) as well. The results suggest a therapeutic potential of B. lupulina but not C. nutans against HSV-2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619382     DOI: 10.1016/s0378-8741(99)00008-2

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  16 in total

1.  The identities and anti-herpes simplex virus activity of Clinacanthus nutans and Clinacanthus siamensis.

Authors:  Paween Kunsorn; Nijsiri Ruangrungsi; Vimolmas Lipipun; Ariya Khanboon; Kanchana Rungsihirunrat; Wanna Chaijaroenkul
Journal:  Asian Pac J Trop Biomed       Date:  2013-04

2.  The anti-amoebic activity of some medicinal plants used by AIDS patients in southern Thailand.

Authors:  Nongyao Sawangjaroen; S Phongpaichit; S Subhadhirasakul; M Visutthi; N Srisuwan; N Thammapalerd
Journal:  Parasitol Res       Date:  2006-01-31       Impact factor: 2.289

3.  Review of Whole Plant Extracts With Activity Against Herpes Simplex Viruses In Vitro and In Vivo.

Authors:  Anna Garber; Lianna Barnard; Chris Pickrell
Journal:  J Evid Based Integr Med       Date:  2021 Jan-Dec

4.  Efficacy and Safety of Clinacanthus nutans Lindau Cream vs. Podophyllin for the Treatment of Adults with Condyloma Acuminata.

Authors:  Sukhum Jiamton; Pattriya Chanyachailert; Yanisorn Nanchaipruek; Nuttagarn Jantanapornchai; Poramin Patthamalai; Pichaya Limphoka; Ya-Nin Nokdhes; Jiraporn Jantaravinid
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-23       Impact factor: 2.650

5.  Chakyunglupulins A and B, two novel 4,8,8-trimethylcyclooct-2-enone derivatives from Barleria lupulina.

Authors:  Ki Hyun Kim; Jon Clardy; Donald Senger; Shugeng Cao
Journal:  Tetrahedron Lett       Date:  2015-05-20       Impact factor: 2.415

6.  Medicinal and ethnoveterinary remedies of hunters in Trinidad.

Authors:  C Lans; T Harper; K Georges; E Bridgewater
Journal:  BMC Complement Altern Med       Date:  2001-11-30       Impact factor: 3.659

7.  Use of complementary and alternative medicines among Malaysian cancer patients: A descriptive study.

Authors:  Maryam Farooqui; Mohamed Azmi Hassali; Aishah Knight Abdul Shatar; Muhammad Aslam Farooqui; Fahad Saleem; Noman Ul Haq; Che Noriah Othman
Journal:  J Tradit Complement Med       Date:  2015-03-18

8.  Clinacanthus Nutans Hexane Extracts Induce Apoptosis Through a Caspase-Dependent Pathway in Human Cancer Cell Lines

Authors:  Pei Ying Ng; Soi Moi Chye; Chew Hee Ng; Rhun Yian Koh; Yee Lian Tiong; Liew Phing Pui; Yong Hui Tan; Crystale Siew Ying Lim; Khuen Yen Ng
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

9.  Clinacanthus nutans Extracts Are Antioxidant with Antiproliferative Effect on Cultured Human Cancer Cell Lines.

Authors:  Yoke Keong Yong; Jun Jie Tan; Soek Sin Teh; Siau Hui Mah; Gwendoline Cheng Lian Ee; Hoe Siong Chiong; Zuraini Ahmad
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-27       Impact factor: 2.629

10.  Antibacterial, antioxidant and Immuno-modulatory properties in extracts of Barleria lupulina Lindl.

Authors:  Reshma Kumari; Sumit Kumar; Ashwani Kumar; Kapil Kumar Goel; Ramesh Chandra Dubey
Journal:  BMC Complement Altern Med       Date:  2017-11-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.